KIT and prostate cancer: Koran S et al.43 reported that CD117/c-kit expression in circulating tumor cells of advanced prostate cancer patients is associated with increased aggressiveness, decreased survival, and resistance to tyrosine kinase inhibitors by promoting cancer stem cell properties.